BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 29517541)

  • 21. Physiological uptake of 18F-FDG in the vertebral bone marrow in healthy adults on PET/CT imaging.
    Shen G; Liang M; Su M; Kuang A
    Acta Radiol; 2018 Dec; 59(12):1487-1493. PubMed ID: 29486597
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Transurethral implantation of macroplastique for the treatment of female stress urinary incontinence secondary to urethral sphincter deficiency.
    Radley SC; Chapple CR; Mitsogiannis IC; Glass KS
    Eur Urol; 2001 Apr; 39(4):383-9. PubMed ID: 11306875
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Correlation Between Baseline 18F-FDG PET/CT Findings and CD38- and CD138-Expressing Myeloma Cells in Bone Marrow and Clinical Parameters in Patients with Multiple Myeloma.
    Cengiz A; Arda HÜ; Döğer F; Yavaşoğlu İ; Yürekli Y; Bolaman AZ
    Turk J Haematol; 2018 Aug; 35(3):175-180. PubMed ID: 29806594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cross-linked polydimethylsiloxane injection for female stress urinary incontinence: results of a multicenter, randomized, controlled, single-blind study.
    Ghoniem G; Corcos J; Comiter C; Bernhard P; Westney OL; Herschorn S
    J Urol; 2009 Jan; 181(1):204-10. PubMed ID: 19013613
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pulmonary FDG uptake without a CT counterpart - a pitfall in interpreting PET/CT images.
    Schreiter N; Nogami M; Buchert R; Froeling V; Brenner W; Diekmann F
    Acta Radiol; 2011 Jun; 52(5):513-5. PubMed ID: 21498287
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Role of delayed-time-point imaging during abdominal and pelvic cancer screening using FDG-PET/CT in the general population.
    Naganawa S; Yoshikawa T; Yasaka K; Maeda E; Hayashi N; Abe O
    Medicine (Baltimore); 2017 Nov; 96(46):e8832. PubMed ID: 29145346
    [TBL] [Abstract][Full Text] [Related]  

  • 27. FDG PET/CT in Hepatoid Adenocarcinoma of the Lung.
    Wang S; Li M; Chen H; Li J; Zeng Q
    Clin Nucl Med; 2016 Jul; 41(7):e340-1. PubMed ID: 27124679
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Primary Tumor ¹⁸F-FDG Avidity Affects the Performance of ¹⁸F-FDG PET/CT for Detecting Gastric Cancer Recurrence.
    Kim SJ; Cho YS; Moon SH; Bae JM; Kim S; Choe YS; Kim BT; Lee KH
    J Nucl Med; 2016 Apr; 57(4):544-50. PubMed ID: 26678615
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Galactocele, Pitfall for the Evaluation by 18F-FDG PET/CT.
    Ceyrat Q; Ziade C; Tlili G; Fernandez P; Meyer M
    Clin Nucl Med; 2018 Jul; 43(7):e237-e238. PubMed ID: 29847317
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of 18F-FDG PET/CT with retrograde filling of the urinary bladder in patients with suspected pelvic malignancies.
    Vicente AM; Castrejón AS; Muñoz AP; Woll PP; García AN
    J Nucl Med Technol; 2010 Sep; 38(3):128-37. PubMed ID: 20807854
    [TBL] [Abstract][Full Text] [Related]  

  • 31. 18F-FDG PET/CT in Metastatic Pilomatrix Carcinoma.
    Vadrucci M; Gilardi L; Crivelli F; Baroli A; Lomuscio G
    Clin Nucl Med; 2016 Dec; 41(12):e525-e526. PubMed ID: 27824328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diagnostic performance of
    Hotta M; Minamimoto R; Yano H; Gohda Y; Shuno Y
    Cancer Imaging; 2018 Jan; 18(1):4. PubMed ID: 29378659
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of postoperative male urinary incontinence using transurethral macroplastique injections.
    Kylmälä T; Tainio H; Raitanen M; Tammela TL
    J Endourol; 2003 Mar; 17(2):113-5. PubMed ID: 12689406
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Clinical significance of incidental [18 F]FDG uptake in the gastrointestinal tract on PET/CT imaging: a retrospective cohort study.
    Shmidt E; Nehra V; Lowe V; Oxentenko AS
    BMC Gastroenterol; 2016 Oct; 16(1):125. PubMed ID: 27716085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. An Open Multicenter Study of Clinical Efficacy and Safety of Urolastic, an Injectable Implant for the Treatment of Stress Urinary Incontinence: One-Year Observation.
    Futyma K; Miotła P; Gałczyński K; Baranowski W; Doniec J; Wodzisławska A; Jóźwik M; Oniszczuk M; Rechberger T
    Biomed Res Int; 2015; 2015():851823. PubMed ID: 26106616
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Female stress urinary incontinence: office-based urethral bulking agent procedure.
    Ramsden M; Williams E; Siegel S
    Urol Nurs; 2010; 30(5):297-305. PubMed ID: 21067095
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Pelvic Lymph Node Staging by Combined
    Pichler R; De Zordo T; Fritz J; Kroiss A; Aigner F; Heidegger I; Virgolini I; Horninger W; Uprimny C
    Clin Genitourin Cancer; 2017 Jun; 15(3):e387-e395. PubMed ID: 27601364
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Diagnostic value of additional 18F-FDG PET/CT imaging using a vaginal catheter in patients with paravaginal malignant lesions.
    Ucak Semirgin S; Basoglu T; Atmaca Saglik B; Sahin M; Yapici O
    Nucl Med Commun; 2016 Dec; 37(12):1260-1266. PubMed ID: 27466019
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Urethral Macroplastique injection as a treatment for female stress incontinence].
    Sander P; Mouritsen AL; Lose G
    Ugeskr Laeger; 2004 Aug; 166(36):3100-2. PubMed ID: 15387310
    [No Abstract]   [Full Text] [Related]  

  • 40. Preparation methods prior to PET/CT scanning that decrease uptake of 18F-FDG by myocardium, brown adipose tissue, and skeletal muscle.
    Shao D; Tian XW; Gao Q; Liang CH; Wang SX
    Acta Radiol; 2017 Jan; 58(1):10-18. PubMed ID: 26936898
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.